Formulations for Pioneering Drugs

ProJect Pharmaceutics offers formulation and process development for parenteral drug products to the pharmaceutical and biotech industry.

Drug Formulation Development​

Quality-by-Design based drug formulation development: development of parenteral formulations and innovative drug delivery systems for all kinds of biopharmaceutics, cytotoxics and viral/non-viral nanoparticular systems.

Cytotoxic Drug Development

Formulation and lyophilization process development for cytotoxic and other highly potent drugs, including Antibody Drug Conjugates (ADCs).

ADC Development

Innovative formulation and lyophilization process development for Antibody Drug Conjugates (ADCs)

High Protein Concentration Formulations

A science-based approach to develop best-in-class high protein formulations for convenient use in pre-filled syringes, cartridges and dual chamber systems.

Lyophilization Process Development

The art of developing efficient and robust freeze drying cycles which also work under conditions of large scale manufacturing.

Aseptic Preclinical Batch Manufacturing / Non-GMP Pilot Study Supply

Non-GMP pilot batch manufacturing of pre-clinical batches for liquid and lyophilized drug delivery systems: ensured sterility through use of permeable lyophilization bags, and supported by valid documentation for pre-clinical study supply or Tox batch supply.